Protein Engineering Market Trends

Protein Engineering Market size was valued at USD 2.52 Billion in 2023 and is poised to grow from USD 2.94 Billion in 2024 to USD 10.03 Billion by 2032, growing at a CAGR of 16.60% during the forecast period (2025-2032).

Protein engineering providers should focus on increasing awareness regarding their offerings and their benefits to maximize their business scope. Collaborations will also play a vital role in helping companies expand their business across the world. Focusing on personalized medicine and biopharmaceutical production will pay off big time for all protein engineering companies in the future. Increasing the affordability of protein engineering products will also be a key trend for protein engineering providers to focus on going forward.  'Thermo Fisher Scientific Inc.', 'Merck KGaA', 'Agilent Technologies, Inc.', 'Genscript Biotech Corporation', 'Codexis, Inc.', 'Danaher Corporation', 'Bio-Rad Laboratories, Inc.', 'Bruker Corporation', 'PerkinElmer, Inc.', 'Creative Biomart', 'Abcam plc', 'Enzyme by Design Ltd.', 'Twist Bioscience Corporation', 'Cyrus Biotechnology, Inc.', 'Integrated DNA Technologies, Inc. (IDT)', 'New England Biolabs', 'Genentech, Inc.', 'Promega Corporation', 'Sutro Biopharma, Inc.'

Personalized medicine has been growing in popularity around the world as people look for more effective treatments for their conditions. Increasing specificity of disease impact based on genetics has led to high use of personalized medicine and protein engineering plays a crucial role in the development of the same. This is why the growing popularity of personalized medicine will also help protein engineering companies expand their business.  

Protein engineering companies can explore the use of directed evolution to mimic natural selection in laboratories thereby creating new products that are not entirely synthetic in nature. This approach can also help researchers create more variants of protein that can be used in multiple applications to enhance the scope of treatment of chronic diseases.

High investments in medical R&D and presence of a developed healthcare infrastructure help North America to maintain a top spot in the global protein engineering market. Rising demand for personalized medicine and advancements in protein engineering technologies are also helping create new business scope in this region. Canada and the United States are forecasted to be the leading revenue generators for protein engineering providers operating in this region. High investments in medical R&D by governments in this region will also promote the demand for protein engineering going forward. Moreover, the presence of top pharmaceutical and biotechnology companies in this region will also help the dominance in the long run.